Latest Health News
Libya Eliminates Trachoma as Public Health Problem
The WHO validated Libya's elimination of trachoma, making it the 59th country globally and 10th in the Eastern Mediterranean Region to eliminate this neglected tropical disease. This achievement protects future generations from preventable blindness and reflects Libya's commitment to overcoming tropical diseases despite ongoing challenges
.
Ultrasound-Activated Nanobubbles Break Down Tumor Barriers
Researchers at Case Western Reserve University developed ultrasound-activated nanobubbles that breach solid tumors' defensive barriers, enabling cancer drugs and immune cells to penetrate treatment-resistant cancers. The technology activates the body's own immune defenses without additional therapies, with potential clinical trials possible within two years
.
Single Stem Cell Generates 14 Million Tumor-Killing NK Cells
Chinese Academy of Sciences scientists unveiled a breakthrough method to mass-produce powerful natural killer (NK) cells from cord blood stem cells in the laboratory. This streamlined process generates enormous numbers of highly potent NK cells, including CAR-equipped versions designed to hunt specific cancers
.
CRISPR Gene Drive System Reverses Antibiotic Resistance
UC San Diego researchers developed a new CRISPR-based tool called pPro-MobV that strips away drug resistance from bacteria by spreading genetic 'fixes' through bacterial populations. The technology can neutralize antibiotic resistance in large target populations and potentially pairs with bacteriophages to combat the projected 10 million annual deaths from antibiotic-resistant superbugs by 2050
.
Booster Vaccines Reduce COVID-19 Deaths and Hospitalizations
A study of over 3 million English adults found that autumn 2022 COVID-19 booster vaccines significantly reduced hospitalization and death risks, with similar effectiveness between Moderna and Pfizer-BioNTech formulations. Protection effectiveness declined over time, providing further evidence supporting booster vaccination strategies
.
Long-Acting HIV Injectable Shows Superior Efficacy Over Daily Oral Therapy
ViiV Healthcare's final LATITUDE trial data confirm that Cabenuva (cabotegravir + rilpivirine) long-acting injectable treatment reduced virological failure risk by nearly half compared to daily oral therapy in people with adherence challenges. Results were published in the New England Journal of Medicine and demonstrate sustained viral load suppression through 48 weeks
.
Amivantamab Receives FDA Breakthrough Therapy Designation for Head and Neck Cancer
Johnson & Johnson's RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) received FDA breakthrough therapy designation for advanced HPV-unrelated head and neck cancer. Phase 1b/2 trial data presented at the 2025 ESMO Congress showed promising clinical activity with rapid and durable responses in heavily pretreated patients
.
Global Violence Against Health Workers Escalates Dramatically
The World Health Professions Alliance warns of sustained escalation in violence, intimidation, and persecution of health professionals across multiple regions since the COVID-19 pandemic, particularly in Syria, Sudan, Iran, Ukraine, and Gaza. Health workers face arrest, detention, and harassment for treating patients, threatening the foundations of healthcare systems
.
Ā£3 Million Funding Launched for Antibiotic Discovery Breakthroughs
Imperial College London received Ā£3 million in new funding as part of an 18-project initiative across 17 countries focused on transforming antibiotic discovery for Gram-negative bacteria, a leading driver of antibiotic resistance deaths. The project leverages Imperial's Drug Discovery Hub and London BioFoundry infrastructure for experimental work
.
WHO Validates Multiple Neglected Tropical Disease Achievements in 2025
In 2025 alone, nine countries were validated, verified, or certified by WHO for achieving control, elimination, or eradication targets for neglected tropical diseases affecting one billion people globally. These milestones represent progress toward WHO's roadmap goals for neglected tropical diseases spanning 2021-2030
.